These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 7960232

  • 1. Pathogenetic significance of p53 and c-Ki-ras gene mutations and human papillomavirus DNA integration in adenocarcinoma of the uterine cervix and uterine isthmus.
    Jiko K, Tsuda H, Sato S, Hirohashi S.
    Int J Cancer; 1994 Dec 01; 59(5):601-6. PubMed ID: 7960232
    [Abstract] [Full Text] [Related]

  • 2. Frequent occurrence of p53 gene mutations in uterine cancers at advanced clinical stage and with aggressive histological phenotypes.
    Tsuda H, Hirohashi S.
    Jpn J Cancer Res; 1992 Nov 01; 83(11):1184-91. PubMed ID: 1336492
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Analysis and clinical implications of K-ras gene mutations and infection with human papillomavirus types 16 and 18 in primary adenocarcinoma of the uterine cervix.
    Tenti P, Romagnoli S, Silini E, Pellegata NS, Zappatore R, Spinillo A, Zara C, Ranzani GN, Carnevali L.
    Int J Cancer; 1995 Feb 20; 64(1):9-13. PubMed ID: 7665253
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mutations of p53 and human papillomavirus infection in cervical carcinoma.
    Paquette RL, Lee YY, Wilczynski SP, Karmakar A, Kizaki M, Miller CW, Koeffler HP.
    Cancer; 1993 Aug 15; 72(4):1272-80. PubMed ID: 8393371
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
    Stenzel A, Semczuk A, Rózyńskal K, Jakowicki J, Wojcierowski J.
    Pathol Res Pract; 2001 Aug 15; 197(9):597-603. PubMed ID: 11569923
    [Abstract] [Full Text] [Related]

  • 14. Human papillomavirus infection and TP53 gene mutation in primary cervical carcinoma.
    Kim JW, Cho YH, Lee CG, Kim JH, Kim HK, Kim EJ, Han KT, Namkoong SE.
    Acta Oncol; 1997 Aug 15; 36(3):295-300. PubMed ID: 9208900
    [Abstract] [Full Text] [Related]

  • 15. Infrequent occurrence of high-risk human papillomavirus and of p53 mutation in minimal deviation adenocarcinoma of the cervix.
    Toki T, Zhai YL, Park JS, Fujii S.
    Int J Gynecol Pathol; 1999 Jul 15; 18(3):215-9. PubMed ID: 12090589
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas.
    Ikenberg H, Matthay K, Schmitt B, Bauknecht T, Kiechle-Schwarz M, Göppinger A, Pfleiderer A.
    Cancer; 1995 Jul 01; 76(1):57-66. PubMed ID: 8630877
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix.
    Kessis TD, Slebos RJ, Han SM, Shah K, Bosch XF, Muñoz N, Hedrick L, Cho KR.
    Am J Pathol; 1993 Nov 01; 143(5):1398-405. PubMed ID: 8238255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.